55242 Federal Register / Vol. 74, No. 206 / Tuesday, October 27, 2009 / Notices 

review by the Office of Management and 

Budget (OMB) under the Paperwork 

Reduction Act. If the proposed project is 

research involving human subjects, the 

applicants must comply with 

Department of Health and Human 

Services regulations (45 CFR part 46) 

and, if applicable, Food and Drug 

Administration regulations (21 CFR 

parts 50 and 56), regarding the 

protection of human subjects. The 

applicants must ensure that the project 

will be subject to initial and continuing 

review by the appropriate institutional 

review boards. Overall, by providing 

additional scientific information for the 

risk assessment process, data generated 

from this research will support other 

researchers conducting human health 

assessments involving these substances. 

Below are the mechanisms for 

implementing SSARP. The status of 

SSARP in addressing priority data needs 

of the first 60 priority hazardous 

substances through these mechanisms 

was described in a Federal Register 

Notice on December 13, 2005 (70 FR 

73749). 

A. TSCA/FIFRA 

In developing and implementing 

SSARP, ATSDR and EPA established 

procedures to identify priority data 

needs of common interest to multiple 

federal programs. Where practicable, 

these data needs will be addressed 

through a program of toxicologic testing 

under TSCA or FIFRA. This part of the 

research will be conducted according to 

established TSCA/FIFRA procedures 

and guidelines. 

B. Private-Sector Voluntarism 

As part of SSARP, on February 7, 

1992, ATSDR announced a set of 

proposed procedures for conducting 

voluntary research (57 FR 4758). 

Revisions based on public comments 

were published on November 16, 1992 

(57 FR 54160). ATSDR strongly 

encourages private-sector organizations 

to propose research to address priority 

data needs at any time until ATSDR 

announces that research has already 

been initiated for a specific priority data 

need. Private-sector organizations may 

volunteer to conduct research to address 

specific priority data needs identified in 

this notice by submitting a letter of 

intent. 

The letter of intent should be a brief 

statement (1–2 pages) that identifies the 

priority data need(s) to be filled and the 

methods to be used. TASARC will 

review these proposals and recommend 

to ATSDR the voluntary research 

projects that should be pursued—and 

how they should be conducted—with 

the volunteer organizations. ATSDR will 

enter into only those voluntary research 

projects that lead to high-quality, peerreviewed scientific work. Additional 

details regarding the process for 

voluntary research are in the Federal 

Register Notices cited in this section. 

C. CERCLA 

Those priority data needs not 

addressed by TSCA/FIFRA or initial 

voluntarism will be considered for 

funding by ATSDR through its CERCLA 

budget. Much of this research program 

is envisioned to be unique to CERCLA— 

for example, research on substances not 

regulated by other programs, or research 

needs specific to public health 

assessments. 

Mechanisms to address these priority 

data needs may include a second call for 

voluntarism. Again, scientific peer 

review of study protocols and results is 

a requirement for all research conducted 

under this auspice. 

ATSDR encourages private-sector 

organizations and other governmental 

programs to use ATSDR’s priority data 

needs to plan their research activities. 

Dated: October 21, 2009. 

Ken Rose, 

Director, Office of Policy, Planning, and 

Evaluation, National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. E9–25776 Filed 10–26–09; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; AA–1 and AA–4 Study 

Sections Members Conflict. 

Date: November 10, 2009. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: Lorraine Gunzerath, PhD, 

MBA, Scientific Review Officer, National 

Institute on Alcohol Abuse and Alcoholism, 

Office of Extramural Activities, Extramural 

Project Review Branch, 5635 Fishers Lane, 

Room 2121, Bethesda, MD 20892–9304, 301– 

443–2369, Igunzera@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the securing of 

meeting attendees. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: October 19, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–25623 Filed 10–26–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts in Language and Cognition. 

Date: November 12, 2009. 

Time: 3:30 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Officer, Center for 


pwalker on DSK8KYBLC1PROD with NOTICES